New York State Common Retirement Fund’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-426
Closed 3544
2022
Q2
$0 Sell
426
-28,400
-99% -$47.7K ﹤0.01% 3589
2022
Q1
$159K Sell
28,826
-4,569
-14% -$29K ﹤0.01% 2895
2021
Q4
$323K Sell
33,395
-1,484
-4% -$20.6K ﹤0.01% 2670
2021
Q3
$624K Sell
34,879
-4,024
-10% -$87.5K ﹤0.01% 2346
2021
Q2
$950K Buy
38,903
+7,103
+22% +$178K ﹤0.01% 2264
2021
Q1
$843K Buy
31,800
+5,100
+19% +$74.5K ﹤0.01% 2197
2020
Q4
$203K Hold
26,700
﹤0.01% 2756
2020
Q3
$134K Hold
26,700
﹤0.01% 2817
2020
Q2
$160K Hold
26,700
﹤0.01% 2742
2020
Q1
$119K Hold
26,700
﹤0.01% 2698
2019
Q4
$254K Sell
26,700
-9,200
-26% -$89K ﹤0.01% 2629
2019
Q3
$282K Hold
35,900
﹤0.01% 2601
2019
Q2
$565K Buy
35,900
+28,700
+399% +$463K ﹤0.01% 2316
2019
Q1
$130K Hold
7,200
﹤0.01% 2883
2018
Q4
$116K Buy
+7,200
New +$131K ﹤0.01% 2921

Other funds holding RUBY

New York State Common Retirement Fund's RUBY Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Rubius Therapeutics, Inc (RUBY) in Q3 2022, closing a stake of 426 shares.

New York State Common Retirement Fund first reported a position in RUBY in Q4 2018 and held it in 15 quarters. The position peaked at $950K in Q2 2021. 62 funds tracked by Wall St. Rank hold RUBY as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Rubius Therapeutics, Inc position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 426 Rubius Therapeutics, Inc shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Rubius Therapeutics, Inc in Q4 2018 and held it in 15 quarters.
  • New York State Common Retirement Fund's Rubius Therapeutics, Inc position peaked at $950K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.